一项基于计算遗传学和转录学的研究提名了用于治疗慢性疼痛的药物重用候选人
Alanna C Cote1, Keira J A Johnston2, Carina Seah1
1Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
EBioMedicine
|November 8, 2025
概括
这项研究引入了一个新的基因信息框架,以寻找治疗慢性疼痛的药物重用候选人. 它确定了894种潜在药物,包括210种FDA批准的药物,为疼痛管理提供了新的途径.
科学领域:
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 慢性疼痛影响20-30%的人口,缺乏有效的长期药物治疗.
- 全基因组关联研究 (GWAS) 表明慢性疼痛具有独特的遗传基础.
- 目前的干预措施在控制慢性疼痛率方面表现出有限的成功.
研究的目的:
- 开发一种新的基因信息框架,用于识别慢性疼痛的药物改用候选者.
- 利用功能性基因组学和因果推理来发现潜在的治疗方法.
- 确定可以用于慢性疼痛管理的现有药物.
主要方法:
- 利用签名映射,一种功能性基因组学方法,来比较疾病和药物的转录效应.
- 使用GWAS数据对慢性疼痛和药物使用的双样本孟德尔随机化分析.
- 综合遗传和转录基因数据,以提名治疗候选者.
主要成果:
- 在三种慢性疼痛特征中确定了894种潜在的候选药物.
- 在候选人中发现了210种美国处方药,涵盖了各种药物类别.
- 门德尔的随机化表明,阿片类药物和抗血栓剂暴露与慢性疼痛责任之间存在因果关系.
结论:
- 通过使用遗传和转录基因数据,建立了用于慢性疼痛药物重定向的新框架.
- 识别了FDA批准的药物,假设它们对预防或治疗慢性疼痛有益.
- 强调需要进一步实验和临床验证这些药物重定向机会.
相关概念视频
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
897
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
897
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K


